Oral Health

otezla 30mg single

Otezla Approved to Treat Oral Ulcers Associated With Behçet’s Disease

The Food and Drug Administration (FDA) has approved Otezla (apremilast; Celgene) for the treatment of adult patients with oral ulcers associated with Behçet’s disease. The approval was based on data from the placebo controlled, double blind phase 3 RELIEF study which evaluated the efficacy and safety of apremilast in patients with Behçet’s disease and active…